4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the Food and Drug Administration in the past week.

Advertisement

1. The lung cancer drug Alunbrig is now available as 180 milligram tablets.

2. Botox may now be used for the temporary improvement of moderate to severe forehead lines.

3. Glatiramer acetate injection is a generic version of Teva’s multiple sclerosis drug Copaxone.

4. The cobas Zika test is used to detect Zika virus in blood donations.

More articles on supply chain:

Jury orders AbbVie to pay $140M+ for misrepresenting testosterone drug risks
J&J exits insulin pump business: 4 things to know
CVS rolls out medication management tool: 4 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.